Medical Conditions
   Abdominal Pain, Recurrent
   Acute Lymphoblastic Leukemia
   Acute Otitis Media
   Acute Strep Throat
   Atopic Dermatitis (Eczema)
   Attention-Deficit Hyperactivity Disorder
   Attention-Deficit Hyperactivity Disorder (ADHD)
   Breast Enlargement, Premature
   Breath-Holding Spells
   Care of the Premature Infant
   Celiac Disease
   Chickenpox Immunization
   Coarctation of the Aorta
   Congenital Hip Dysplasia
   Coxsackie A16
   Cyclic Vomiting Syndrome (CVS)
   Developmental Dysplasia of the Hip
   Diabetic Mother, Infant of
   Ear Infection
   Eating Disorders
   Enlarged Lymph Nodes
   Erythema Multiforme
   Eye Problems Related to Headache
   Febrile Seizure
   Fetal Alcohol Syndrome
   Fifth Disease (Erythema Infectiosum)
   Food Born Illnesses
   Fragile X Syndrome
   Gastroenteritis, Viral
   Gastroesophageal Reflux
   Hand Foot and Mouth
   Head Lice
   Headache Related to Eye Problems
   Hepatitis A
   Hepatitis A Immunization
   Hepatitis B
   Hepatitis B Immunization
   Hepatitis C
   Hib Immunization
   High Blood Pressure
   Infant of a Diabetic Mother
   Infectious Mononucleosis
   Influenza Immunization
   Kawasaki Syndrome
   Language Development in Young Children
   Lead Poisoning
   Lung Hypoplasia
   Lyme Disease
   Mental Health
   MMR Immunization
   Obesity in Childhood
   Otitis Media, Acute
   Pneumococcal Conjugate Immunization
   Polio Immunization
   Premature Thelarche
   Prematurity, Retinopathy of
   Pulmonary Hypertension
   Pulmonary Hypertension (PPH & SPH)
   Retinopathy of Prematurity
   Rheumatic Fever, Acute
   Ringworm (Tinea)
   Rubella (German Measles)
   Separation Anxiety
   Speech Development in Young Children
   Stevens-Johnson Syndrome
   Strep Throat-Acute
   Strep Throat-Recurrent
   Stuttering and the Young Child
   Swine Flu
   Swine Flu (H1N1) FAQ
   Swine Flu (H1N1) Vaccine
   Swollen Glands
   Tear Duct, Blocked
   Tetralogy of Fallot
   Thyroid Problems
   Tinea (ringworm infection)
   Toxic Shock Syndrome
   Turner Syndrome
   Underdeveloped Lungs
   Urinary Tract Infection
   Varicella or Chickenpox
   Varivax Immunization
   Vesicoureteral Reflux
   Wilson Disease
New Parents
Special Needs
Web Links
What's Going Around?
Visual Symptom Checker


Medical Conditions


by Joseph Morelli, M.D.
Associate Professor of Dermatology and Pediatrics
University of Colorado School of Medicine

What is a hemangioma?

A hemangioma is a benign tumor of the blood vessels ("capillary endothelium"). Some hemangiomas occur as birthmarks, often spontaneously improving.


What causes hemangiomas?

The cause of hemangiomas is unknown.


Who gets hemangiomas?

Hemangiomas are a very common benign tumor of infancy. Hemangiomas occur in up to 10% of the population, most commonly in females and in premature infants.


How do hemangiomas cause disease?

Because they are tumors, hemangiomas have a mass effect, meaning they take up space or room, which is caused by the growth of the tumor.


What are the common findings of hemangiomas?

Only 20% of hemangiomas are present at birth. The other 80% occur during the first two months of life, usually within the first month. They appear as white-gray blue flat spots, swollen "spider veins" (telangiectasias), or raised bumps. Then, they undergo a rapid growth phase, lasting from six to nine months, in which they grow faster than the child's rate of growth. After this time, the growth of the hemangioma slows and approximates the growth rate of the child. The stable growth phase lasts until 12 to 18 months of age at which time the hemangioma begins to undergo "involution." During the involution phase, the tumor shrinks on its own, without the need for treatment. Maximum shrinkage occurs in 50% of children by age 5, in 70% of children by age 7, and in 90% of children by age 9.

Parents should know that hemangiomas do not always completely disappear; in some cases, the affected skin does not return to its normal appearance.

Some hemangiomas leave recognizable marks following shrinkage of the tumor. These include decreased skin color; spider veins; excess lax skin; fibrous fatty deposits; and scarring, if the skin has broken down over the hemangioma.

Hemangiomas can appear as three different forms. The first type is the superficial bright red form, formerly known as the strawberry mark. The second type is the deep blue nodule, formerly known as a cavernous hemangioma. The third type is a combination of the superficial and the deep forms, which is called a mixed hemangioma. Commonly, the terms "superficial," "deep," and "mixed" are used to describe the three different types of hemangiomas.


How are hemangiomas diagnosed?

Hemangiomas usually are diagnosed based on an examination and the history of the lesion. Occasionally, magnetic resonance imaging is performed to determine the depth of involvement of the tumor; however, this procedure is rarely necessary or helpful.


What are the complications of hemangiomas?

Most hemangiomas are uncomplicated and do not require treatment. Complications of hemangiomas include ulceration (a breakdown of the overlying skin), infection, interference with a vital function, and, even, high output cardiac failure. Initially, the Kasabach-Merritt syndrome, which is a bleeding disorder, was thought to occur with hemangiomas; however, now, it is thought to occur with hemangioendotheliomas, which are a much less common and more aggressive tumor. Ulceration is the most common complication of hemangiomas. Ulcerated hemangiomas occur most commonly on the lip and in the diaper areas. If a lesion is ulcerated, it is at risk for infection. Staphylococcus aureus is the most common bacteria in infected hemangiomas. Vision, breathing, eating, urination, and bowel movements may all be obstructed by large, rapidly growing hemangiomas.


How are hemangiomas treated?

Most hemangiomas do not require treatment. Ulcerated hemangiomas are best treated with a specific type of laser. This leads to rapid healing of the open area. Infection is treated with specific antibiotics for Staphylococcus aureus. Large, rapidly growing hemangiomas, or hemangiomas that interfere with a vital function, are treated with systemic therapy. (Systemic therapy is treatment that affects the whole body, as opposed to localized treatment, and can be given either by mouth or intravenous injection.) Prednisone is the initial treatment of choice. It usually is given for two weeks. If after two weeks of therapy the tumor growth has been slowed, treatment is then tapered over the next four weeks. If there is no initial effect of therapy, the dose of prednisone is maintained for another two weeks. The patient should be seen every two weeks during therapy. Occasionally, after therapy is stopped, there will be some rebound growth of the tumor. If this growth is substantial, therapy should be restarted. Interferon-alfa also has been used to treat hemangiomas. The use of interferon-alfa should be reserved for hemangiomas that do not respond to prednisone therapy.


How are hemangiomas prevented?

Currently, hemangiomas cannot be prevented.


What research is being performed?

The research most applicable to hemangiomas is being performed in the area of inhibiting the formation of new blood vessels (anti-angiogenesis). Since hemangiomas are vascular tumors, any therapy that inhibits blood vessel formations should impede hemangioma growth. At this time, agents that inhibit blood vessel formation have not yet been used for hemangioma therapy.


Are there links to other information?

A support group for families with children with hemangiomas is available at: The National Organization of Vascular Anomalies, P.O. Box 0358, Findlay, OH 45839-0358, phone number: (419) 425-1593, e-mail: and on the web at



Rasmussen JE. Vascular birthmarks in children. Dermatology Nursing 10:169-177, 1998.

Frieden IJ. Which hemangiomas to treat-and how? Arch Dermatol 133:1593-1595, 1997.

Morelli JG. Hemangiomas and vascular malformations. Pediatric Annals 25:91-96, 1996.

About the Author

Joseph received his undergraduate degree from the University of Pennsylvania, graduating Summa cum Laude with honors in biophysics. He completed his medical school training in 1981 from the Harvard University School of Medicine.

He is board certified in pediatrics and dermatology and completed his residencies in the same specialties. Joseph is a Pediatric Dermatologist with major interest in birthmarks and vascular lesions.

He spends most of his free time coaching Little League Baseball and Midget Football!

Copyright 2012 Joseph Morelli, M.D., All Rights Reserved

Health Center

Select from over 100 symptoms to learn about managing your child's illness.